Advertisement

Topics

CML Blast Phase Outcomes Remain Poor in TKI Era, Prognostic Factors Identified

00:35 EDT 9 Aug 2017 | Cancer Networks

Patients with chronic myeloid leukemia in the blast phase pose a significant therapeutic challenge and have poor survival, even in the tyrosine kinase inhibitor era, according to a new study.

Original Article: CML Blast Phase Outcomes Remain Poor in TKI Era, Prognostic Factors Identified

NEXT ARTICLE

More From BioPortfolio on "CML Blast Phase Outcomes Remain Poor in TKI Era, Prognostic Factors Identified"

Quick Search
Advertisement